Seed Newsvine
Major drugmaker loses $27 billion in market value after failed trial
-
Two companies announced on Thursday that the heart disease drug they had
been developing failed its Phase III trial.
6 minutes ago
1 comment:
http://youtu.be/xoiyCrf5qKs
Post a Comment